Open Access
| Issue |
Med Sci (Paris)
Volume 40, Number 12, Décembre 2024
Épigénétique : développement et destin cellulaire
|
|
|---|---|---|
| Page(s) | 982 - 985 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2024169 | |
| Published online | 20 December 2024 | |
- Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front Oncol 2019 ; 9 : 713. [CrossRef] [PubMed] [Google Scholar]
- Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: Lessons from Epstein-Barr virus. Annu Rev Immunol 2007 ; 25 : 587–617. [CrossRef] [PubMed] [Google Scholar]
- Naughton P, Enright F, Lucey B. Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response. Curr Opin Infect Dis 2024 ; 37 : 157–63. [CrossRef] [PubMed] [Google Scholar]
- Tangye SG, Latour S. Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. Blood 2020 ; 135 : 644–55. [CrossRef] [PubMed] [Google Scholar]
- Martin E, Winter S, Garcin C, et al. Role of IL-27 in Epstein-Barr virus infection revealed by IL-27RA deficiency. Nature 2024 ; 628 : 620–9. [CrossRef] [PubMed] [Google Scholar]
- Beizavi Z, Zohouri M, Asadipour M, et al. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. Int Rev Immunol 2021 ; 40 : 319–29. [CrossRef] [PubMed] [Google Scholar]
- Mei Y, Lv Z, Xiong L, et al. The dual role of IL-27 in CD4+ T cells. Mol Immunol 2021 ; 138 : 172–80. [CrossRef] [PubMed] [Google Scholar]
- Pratumchai I, Zak J, Huang Z, et al. B cell-derived IL-27 promotes control of persistent LCMV infection. Proc Natl Acad Sci USA 2022 ; 119 : e2116741119. [CrossRef] [PubMed] [Google Scholar]
- Devergne O, Hummel M, Koeppen H, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996 ; 70 : 1143–53. [CrossRef] [PubMed] [Google Scholar]
- Sun R, Wang Y, Abolhassani H. Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies. Expert Rev Clin Immunol 2023 ; 19 : 771–84. [CrossRef] [PubMed] [Google Scholar]
- Bastard P, Gervais A, Le Voyer T, et al. Human autoantibodies neutralizing type I IFNs: From 1981 to 2023. Immunol Rev 2024 ; 322 : 98–112. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.